logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

James C. Yang

national institutes of health
H指数:69
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world treatment patterns and subsequent treatment effectiveness following frontline brigatinib in the ALTA-1L trial
FUTURE ONCOLOGY
IF2.6
2025-12-010
PRE
Ahn, Myung-Ju; Delmonte, Angelo; Ghosh, Sharmistha; Hochmair, Maximilian; Yang, Tsung-Ying; Yang, James Chih-Hsin; Han, Ji-Youn; Hansen, Karin Holmskov; Wu, Yanyu; Wan, Yin; Lin, Huamao Mark; Kretz, Julian; Hupf, Bradley; Kurec, Ahmet Melih; Churchill, Eric N.; Fram, Robert J.; Cabasag, Citadel Jungco; Goriya, Vishal; Zhao, Yuzhe; Campelo, Maria Rosario Garcia
Lazertinib Versus Osimertinib in Previously Untreated EGFR-mutant Advanced NSCLC: A Randomized, Double-blind, Exploratory Analysis From MARIPOSA

拉泽替尼与奥希替尼在先前未经治疗的EGFR突变晚期NSCLC中的比较: 来自MARIPOSA的随机，双盲，探索性分析

Journal of Thoracic Oncology
IF20.8
2025-07-030
OAAI
Se-Hoon Lee; Shun Lu; Hidetoshi Hayashi; Enriqueta Felip; Alexander I. Spira; Nicolas Girard; Yu Jung Kim; Yurii Ostapenko; Pongwut Danchaivijitr; Baogang Liu; Adlinda Alip; Ernesto Korbenfeld; Josiane Mourão Dias; Ki Hyeong Lee; Hailin Xiong; Soon Hin How; Ying Cheng; Gee-Chen Chang; James Chih-Hsin Yang; Benjamin Besse; Michael Thomas; Sujay Shah; Mahadi Baig; Joshua C. Curtin; Jiarui Zhang; John Xie; Tao Sun; Seema Sethi; Miao Wang; Elizabeth Fennema; Mahesh Daksh; Mariah Ennis; Joshua M. Bauml; Byoung Chul Cho
Durvalumab, Tremelimumab, and Platinum Chemotherapy in EGFR Mutation-Positive NSCLC An Open-Label Phase 2 Trial (ILLUMINATE)

Durvalumab，Tremelimumab和铂类化疗在EGFR突变阳性NSCLC中的应用开放标签2期试验 (illumate)

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2025-02-010
OA
Lee, Chee Khoon; Liao, Bin-Chi; Subramaniam, Shalini; Chiu, Chao-Hua; Mersiades, Antony; Ho, Chao-Chi; Brown, Chris; Lai, Chun-Liang; Hughes, Brett G. M.; Yang, Tsung-Ying; O'Byrne, Ken; Luo, Yung-Hung; Yip, Sonia; Ho, Ching-Liang; Bray, Victoria; Su, Wu-Chou; Moore, Melissa; Feng, Wei-Lien; Bai, Ya-Ying; Ford, Kate; Cummins, Michelle M.; Stockler, Martin R.; Solomon, Benjamin J.; John, Thomas; Yang, James Chih-Hsin
The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLC

KEYLYNK-006 III期研究：比较培美曲塞联合奥拉帕利与培美曲塞联合培美曲塞作为转移性非鳞状非小细胞肺癌维持治疗的疗效。

JOURNAL OF THORACIC ONCOLOGY
IF20.8
2025-02-013
PRE
Gray, Jhanelle E.; Schenker, Michael; Sendur, Mehmet Ali Nahit; Leonova, Viktoriya; Kowalski, Dariusz; Kato, Terufumi; Orlova, Rashida; Yang, James Chih-Hsin; Langleben, Adrian; Pilz, Arnold; Ungureanu, Andrei; Mak, Milena Perez; De Angelis, Flavia; Aggarwal, Himani; Zimmer, Zachary; Zhao, Bin; Shamoun, Mark; Kim, Tae Min
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results

转移性结直肠癌中个性化新抗原反应性TCR转导T细胞的过继转移: 2期试验中期结果

NATURE MEDICINE
IF50
2024-07-114
OA
Parkhurst, Maria; Goff, Stephanie L.; Lowery, Frank J.; Beyer, Rachel K.; Halas, Hyunmi; Robbins, Paul F.; Prickett, Todd D.; Gartner, Jared J.; Sindiri, Sivasish; Krishna, Sri; Zacharakis, Nikolaos; Ngo, Lien; Ray, Satyajit; Bera, Alakesh; Shepherd, Ryan; Levin, Noam; Kim, Sanghyun P.; Copeland, Amy; Nah, Shirley; Levi, Shoshana; Parikh, Neilesh; Kwong, Mei Li M.; Klemen, Nicholas D.; Yang, James C.; Rosenberg, Steven A.
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain
MOLECULAR THERAPY
IF12
2024-02-015
PRE
Mikkilineni, Lekha; Natrakul, Danielle A.; Lam, Norris; Manasanch, Elisabet E.; Mann, Jennifer; Weissler, Katherine A.; Wong, Nathan; Brudno, Jennifer N.; Goff, Stephanie L.; Yang, James C.; Ganaden, Micaela; Patel, Rashmika; Zheng, Zhili; Gartner, Jared J.; Martin, Kathryn R.; Wang, Hao-Wei; Yuan, Constance M.; Lowe, Tyler; Maric, Irina; Shao, Lipei; Jin, Ping; Stroncek, David F.; Rosenberg, Steven A.; Kochenderfer, James N.
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results
NATURE MEDICINE
IF50
2023-07-1014
PRE
Gutierrez, Martin; Lam, Wei-Sen; Hellmann, Matthew D.; Gubens, Matthew A.; Aggarwal, Charu; Tan, Daniel Shao Weng; Felip, Enriqueta; Chiu, Joanne W. Y.; Lee, Jong-Seok; Yang, James Chih-Hsin; Garon, Edward B.; Finocchiaro, Giovanna; Ahn, Myung-Ju; Luft, Alexander; Landers, Gregory A.; Basso, Andrea; Ma, Hua; Kobie, Julie; Palcza, John; Cristescu, Razvan; Fong, Lawrence; Snyder, Alexandra; Yuan, Jianda; Herbst, Roy S.
Targeting neddylation sensitizes colorectal cancer to topoisomerase I inhibitors by inactivating the DCAF13-CRL4 ubiquitin ligase complex
NATURE COMMUNICATIONS
IF15.7
2023-06-2316
OAAI
Sun, Yilun; Baechler, Simone A.; Zhang, Xiaohu; Kumar, Suresh; Factor, Valentina M.; Arakawa, Yasuhiro; Chau, Cindy H.; Okamoto, Kanako; Parikh, Anup; Walker, Bob; Su, Yijun P.; Chen, Jiji; Ting, Tabitha; Huang, Shar-yin N.; Beck, Erin; Itkin, Zina; McKnight, Crystal; Xie, Changqing; Roper, Nitin; Nijhawan, Deepak; Figg, William Douglas; Meltzer, Paul S.; Yang, James C.; Thomas, Craig J.; Pommier, Yves
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers

来自转移性人类癌症的抗肿瘤新抗原反应性T细胞的分子特征

Science
IF45.8
2022-01-010
OA
Frank J. Lowery; Sri Krishna; Rami Yossef; Neilesh B. Parikh; Praveen D. Chatani; Nikolaos Zacharakis; Maria R. Parkhurst; Noam Levin; Sivasish Sindiri; Abraham Sachs; Kyle Joseph Hitscherich; Zhiya Yu; Nolan R. Vale; Yong‐Chen Lu; Zhili Zheng; Li Jia; Jared J. Gartner; Victoria K. Hill; Amy R. Copeland; Shirley Nah; Robert V. Masi; Billel Gasmi; Scott Kivitz; Biman C. Paria; Maria Florentin; Sanghyun Peter Kim; Ken‐ichi Hanada; Yong F. Li; Lien T. Ngo; Satyajit Ray; Mackenzie L. Shindorf; Shoshana T. Levi; Ryan Shepherd; Chris Toy; Anup Y. Parikh; Todd D. Prickett; Michael C. Kelly; Rachel K. Beyer; Stephanie L. Goff; James Chih-Hsin Yang; Paul F. Robbins; Steven A. Rosenberg
KEYNOTE-495/KEYIMPACT: INTERIM ANALYSIS OF A RANDOMIZED, BIOMARKER-DIRECTED, PHASE 2 TRIAL OF PEMBROLIZUMAB-BASED COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER (NSCLC)
JOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
2021-11-106
OA
Gutierrez, Martin; Lam, Wei-Sen; Hellmann, Matthew; Gubens, Matthew; Aggarwal, Charu; Tan, Daniel Shao Weng; Felip, Enriqueta; Chiu, Joanne W. Y.; Lee, Jong-Seok; Yang, James Chih-Hsin; Garon, Edward; Finocchiaro, Giovanna; Ahn, Myung-Ju; Luft, Alexander; Landers, Gregory; Basso, Andrea; Ma, Hua; Kobie, Julie; Palcza, John; Cristescu, Razvan; Fong, Lawrence; Snyder, Alexandra; Yuan, Jianda; Herbst, Roy

研究方向

暂未获取到该数据
S
Steven A. Rosenberg
H 指数:219论文数:1,556被引数:19.6万
R
Richard M. Sherry
H 指数:60论文数:205被引数:4.1万
K
Ken‐ichi Hanada
H 指数:32论文数:130被引数:7,249
N
Nicholas P. Restifo
H 指数:150论文数:890被引数:9.6万
M
Mark E. Dudley
H 指数:67论文数:276被引数:4.6万
P
Paul F. Robbins
H 指数:91论文数:314被引数:4.3万
S
Stephanie L. Goff
H 指数:32论文数:201被引数:6,621
D
Donald E. White
H 指数:78论文数:279被引数:3.5万
Q
Qiong J. Wang
H 指数:18论文数:54被引数:2,872
U
Udai S. Kammula
H 指数:52论文数:192被引数:3.0万